ReviewImmunotherapy2016

Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potential.

Lucy M De La Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.